Biofeedback Based System to Enhance Robotic Assisted Gait Training in Children With Cerebral Palsy

Официальное название

AID2GAIT: Biofeedback Based System to Enhance Robotic Assisted Gait Training in Children With Cerebral Palsy

Обзор

The AID2GAIT project aims to develop a biofeedback system with the aim of improving the outcomes of robot-assisted gait training (RAGT) in pediatric patients with cerebral palsy. The physiological signals of children during RAGT therapy sessions, acquired through non-invasive technologies, will be analyzed. These technologies specifically are: * wearable technology (smartwatch), from which the HRV (Heart Rate Variability) signal will be measured; * infrared thermography, from which the temperature in salient facial regions will be obtained; * fNIRS (functional near-infrared spectroscopy), from which information on brain activity and its changes over time will be obtained. Information on the kinematics of the exoskeleton used during RAGT will be extracted. The RAGT will be performed using the Lokomat orthosis (Hocoma), the most widely used exoskeleton in rehabilitation that facilitates a bilaterally symmetrical gait, as the individual actively tries to advance each limb during walking, combined with a patented dynamic body weight support system.

Подробное описание

The entire RAGT treatment will consist of 12 sessions of robotic gait rehabilitation administered over 4 weeks.

The protocol consists of a block paradigm: children will be asked to actively move during the robotic training for the first 30 seconds, followed by a rest period of 30 seconds. The paradigm will be provided in 10 blocks for a total duration of 30 minutes. During each single session, infrared (IR) thermal video, smartwatch signals (HRV- heart rate variability) and the kinematic output of the robot will be recorded. During the first (T1) and the last session of the RAGT (T12), fNIRS will also be recorded together with the assessment of motor skills, revealed by clinical scales. The assessment of fNIRS and clinical scales will be useful to understand the global efficacy of the treatment. Before the start of the experimental trials, parents will be extensively informed about the purpose and protocol of the study and will sign an informed consent form.

For each session, the assessment of the psychophysiological state of the patients will be based on the estimation of the state of physiological parameters, such as heart rate variability (HRV), recorded by a smartwatch and on the assessment of the emotional state of the child by means of an infrared thermal imaging system. The information on the state of the child and the robot will be assessed in real time and will constitute the input data for a machine learning-based model capable of classifying the level of patient engagement. Based on this information, the physiotherapist, who assists the child during the training sessions, will be able to intervene and modify the parameters of the exoskeleton (e.g. push force, body weight support, treadmill speed, range of motion and hip and knee offset). Furthermore, the effectiveness of the entire treatment will be assessed through the administration of clinical tools commonly used in clinical practice and by the assessment of brain activation by means of a non-invasive and portable neuroimaging technique, the fNIRS. These assessments will be conducted by comparing the first and the last training session.

Вмешательства

• Другое RAGT
  Biofeedback based system development to enhance Robotic Assisted Gait Training in cerebral palsy pediatric patients

Первичные конечные точки

• Analysis of variations in the motor skills of patients from T0 (1st RAGT) to T2 (12th RAGT), assessed by GMFM88 clinical scale [Срок оценки: One month (4 weeks) from the beginning of the 1st RAGT (T0)]
• Analysis of variations in the motor skills of patients from T0 (1st RAGT) to T2 (12th RAGT), assessed by MAS clinical scale [Срок оценки: One month (4 weeks) from the beginning of the 1st RAGT (T0)]
• Analysis of variations in the motor skills of patients from T0 (1st RAGT) to T2 (12th RAGT), assessed by WeeFIM clinical scale [Срок оценки: One month (4 weeks) from the beginning of the 1st RAGT (T0)]
• Analysis of variations in the motor skills of patients from T0 (1st RAGT) to T2 (12th RAGT), assessed by PEDSQL clinical scale [Срок оценки: One month (4 weeks) from the beginning of the 1st RAGT (T0)]
• Measurement of heart rate variability of patients [Срок оценки: Two years from the beginning]
• Measurement of fNIRS of patients [Срок оценки: Two years from the beginning]
• Measurement of infrared imaging of patients [Срок оценки: Two years from the beginning]
• Measurement of exoskeleton kinematics [Срок оценки: Two years from the beginning]

Критерии участия

Критерии включения

Children with cerebral palsy aged 3 to 18 years who have a GMFCS level from I to V, with the ability to express discomfort or pain and understanding simple instructions

Критерии исключения

• Medical problems that could interfere with training and restrictions on the use of the robotic device;
• severe lower limb conditions: muscle contractures, instability or subluxation of the hip;
• recent botulinum toxin A injections to the lower limbs;
• uncontrolled seizures;
• open skin disorders and vascular disorders of the lower limbs.
• Contraindications to gait rehabilitation treatment with Lokomat (e.g. weight <10 kg, non-consolidated fractures, cognitive deficits limiting communication).
• Contractures of fixed joints that limit the range of motion of the orthoses
• Inability to properly adjust the harness and/or orthoses

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Модель наблюдения

Когортное

Центры проведения

Италия · 1 центр

• Fondazione Centri di Riabilitazione Padre Pio Onlus - Gli Angeli di Padre Pio — San Giovanni Rotondo

Идентификаторы

NCT: NCT06947889 · D53D23021770001

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗